gip-1 vs glp-1 The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Frontiers | GLP-1/GIP dual agonist

Follow-up consultations are required every six months for active treatment plans and every nine months for maintenance dosing

Our platform offers a streamlined process where you can complete a free assessment quiz to determine your eligibility for a personalized weight loss program

This is significant because 90% of the bodys serotonin is produced in the gut

However, other measures remained unchanged

GLP-1 drugs (like Ozempic, Wegovy, and Mounjaro) are legitimate prescription medications for diabetes and weight loss, but they should only be prescribed by a health professional after an in-person consultation

Overall, its important to talk to your healthcare provider before making any changes or trying a new drug